Stay updated on Enzalutamide in Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Enzalutamide in Prostate Cancer Clinical Trial page.

Latest updates to the Enzalutamide in Prostate Cancer Clinical Trial page
- Check4 days agoChange DetectedThe footer now identifies the ClinicalTrials.gov site as revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check11 days agoChange DetectedA site-wide NIH notice appears above the study record, announcing a website transition and a change in terminology from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference0.6%

- Check18 days agoChange DetectedThe site footer version label changes from v3.7.1 to v3.7.2, with no change to the study record details.SummaryDifference0.1%

- Check25 days agoChange DetectedThe footer’s website revision identifier changes from v3.7.0 to v3.7.1. The study record content remains unchanged.SummaryDifference0.1%

- Check46 days agoChange DetectedA new revision entry (v3.7.0) was added to the history and the previous revision (v3.6.6) was removed, reflecting an update to the record’s audit trail.SummaryDifference0.1%

- Check67 days agoChange DetectedA new revision entry v3.6.6 was added to the history and the previous v3.6.5 entry was removed.SummaryDifference0.1%

Stay in the know with updates to Enzalutamide in Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Enzalutamide in Prostate Cancer Clinical Trial page.